LU91013I2 - ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base - Google Patents
ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de baseInfo
- Publication number
- LU91013I2 LU91013I2 LU91013C LU91013C LU91013I2 LU 91013 I2 LU91013 I2 LU 91013I2 LU 91013 C LU91013 C LU 91013C LU 91013 C LU91013 C LU 91013C LU 91013 I2 LU91013 I2 LU 91013I2
- Authority
- LU
- Luxembourg
- Prior art keywords
- protein
- factor viiic
- compsn
- polypeptide
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Analytical Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Physics & Mathematics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US06/570,062 US5004804A (en) | 1984-01-12 | 1984-01-12 | Method and composition for preparation of factor VIIIC |
US66491984A | 1984-10-26 | 1984-10-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
LU91013I2 true LU91013I2 (fr) | 2003-06-19 |
Family
ID=27075219
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91014C LU91014I2 (fr) | 1984-01-12 | 2003-03-18 | Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91013C LU91013I2 (fr) | 1984-01-12 | 2003-03-18 | ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91015C LU91015I2 (fr) | 1984-01-12 | 2003-03-18 | Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91087C LU91087I2 (fr) | 1984-01-12 | 2004-06-26 | Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91014C LU91014I2 (fr) | 1984-01-12 | 2003-03-18 | Kogentate (Octocog alfa) dans toutes ses formes couvertes par le brevet de base |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
LU91015C LU91015I2 (fr) | 1984-01-12 | 2003-03-18 | Recombinate (Rurioctocog alfa) dans toutes ses formes couvertes par le brevet de base |
LU91087C LU91087I2 (fr) | 1984-01-12 | 2004-06-26 | Advate(Octocog alfa) soustotes ses formes protégées par le brevet de base. |
Country Status (7)
Country | Link |
---|---|
EP (3) | EP0150735B2 (fr) |
JP (5) | JPH0826078B2 (fr) |
AT (2) | ATE224445T1 (fr) |
DE (6) | DE3586402T3 (fr) |
DK (3) | DK165506C (fr) |
LU (4) | LU91014I2 (fr) |
NL (4) | NL300118I2 (fr) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
JPH07106156B2 (ja) * | 1983-10-28 | 1995-11-15 | ジェネティックス、インスティチュ−ト | ファクタ−▲viii▼および関連生産物の製造 |
US7138505B1 (en) | 1984-01-12 | 2006-11-21 | Novartis Vaccines And Diagnostics, Inc. | Factor VIII:C nucleic acid molecules |
ZA852099B (en) * | 1984-03-26 | 1985-12-24 | Meloy Lab | Recombinant factor viii-c. |
FI86885C (fi) * | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
US4965199A (en) * | 1984-04-20 | 1990-10-23 | Genentech, Inc. | Preparation of functional human factor VIII in mammalian cells using methotrexate based selection |
EP0182448A3 (fr) * | 1984-08-24 | 1987-10-28 | Genetics Institute, Inc. | Production de facteur VIII et produits apparentés |
SE8501050D0 (sv) * | 1985-03-05 | 1985-03-05 | Kabivitrum Ab | Biologically active fragments of human antihemophilic factor and method for preparation thereof |
EP0218712B1 (fr) * | 1985-04-12 | 1992-02-26 | Genetics Institute, Inc. | Nouvelles proteines procoagulantes |
KR910006424B1 (ko) * | 1985-08-21 | 1991-08-24 | 인코텍스 비.브이 | 편성브리프(brief) 제조방법 |
US5198349A (en) * | 1986-01-03 | 1993-03-30 | Genetics Institute, Inc. | Method for producing factor VIII:C and analogs |
FI98829C (fi) * | 1986-01-27 | 1997-08-25 | Chiron Corp | Menetelmä rekombinoidun proteiinikompleksin valmistamiseksi, jolla on humaanitekijä VIII:C-aktiivisuutta |
US5595886A (en) | 1986-01-27 | 1997-01-21 | Chiron Corporation | Protein complexes having Factor VIII:C activity and production thereof |
EP0251843A1 (fr) * | 1986-06-06 | 1988-01-07 | Transgene S.A. | Procédé de préparation de facteur VIII à partir de cellules de mammifères |
EP0272304B1 (fr) * | 1986-06-24 | 1994-01-26 | Novo Nordisk A/S | Procede pour produire un complexe actif de coagulation des fragments du facteur viii |
ATE63335T1 (de) | 1986-07-11 | 1991-05-15 | Miles Inc | Herstellung von rekombinantem protein. |
IL83192A (en) * | 1986-07-18 | 1992-11-15 | Gist Brocades Nv | Method for the preparation of proteins with factor viii activity by microbial host cells;expression vectors,host cells,antibodies |
IL84168A0 (en) * | 1986-10-15 | 1988-03-31 | Rorer Int Overseas | Human factor viii-c analogs,process for the preparation thereof and pharmaceutical compositions containing the same |
WO1988005825A1 (fr) * | 1987-01-30 | 1988-08-11 | Biogen N.V. | Procede de production du facteur viii en grande quantite |
CA1339946C (fr) * | 1987-03-31 | 1998-07-07 | Michael J. Griffith | Methode d'ultrapurification pour les polypeptides |
EP0294910B1 (fr) | 1987-06-12 | 1996-09-11 | Immuno Ag | Protéines à activité de facteur VIII, procédé pour leur production utilisant des cellules modifiées par génie génétique et compositions pharmaceutiques les contenant |
DE3737239A1 (de) * | 1987-11-03 | 1989-10-12 | Behringwerke Ag | Gentechnische herstellung von anticoagulatorischem protein pp4 |
US6544771B1 (en) * | 1987-12-11 | 2003-04-08 | Cell Genesys, Inc. | Retroviral gene therapy vectors and therapeutic methods based thereon |
US6140111A (en) * | 1987-12-11 | 2000-10-31 | Whitehead Institute For Biomedical Research | Retroviral gene therapy vectors and therapeutic methods based thereon |
CA2067158A1 (fr) * | 1989-09-14 | 1991-03-15 | R. Alan Hardwick | Methode et appareil utile pour la preparation de compositions pharmaceutiques |
US5610033A (en) * | 1990-04-25 | 1997-03-11 | Novo Nordisk A/S | Method of producing proteins with FVIII activity and/or FVIII derivatives |
DK53792D0 (da) * | 1992-04-24 | 1992-04-24 | Novo Nordisk As | Fremgangsmaade til fremstilling af proteiner |
US5910481A (en) * | 1995-11-13 | 1999-06-08 | Immuno Ag | Hybrid proteins with modified activity |
US6500646B1 (en) * | 1996-12-27 | 2002-12-31 | Mochida Pharmaceutical Co., Ltd. | Cell membrane-directed drugs |
JP5149470B2 (ja) | 1999-02-22 | 2013-02-20 | バクスター・インターナショナル・インコーポレイテッド | 新規のアルブミンを含有していない第viii因子処方物 |
EP1418810A4 (fr) | 2001-08-03 | 2006-08-02 | Us Gov Health & Human Serv | Traitement de l'hemophilie par voie orale |
AU2003269557A1 (en) * | 2002-10-18 | 2004-05-04 | Lg Life Sciences Ltd. | Gene families associated with cancers |
EP1707634A1 (fr) | 2005-03-29 | 2006-10-04 | Octapharma AG | Procédé pour l'isolation de protéines recombinantes |
EP1739179A1 (fr) | 2005-06-30 | 2007-01-03 | Octapharma AG | Transfection stable exempt de sérum et production des protéines recombinantes humaines dans des lignées cellulaires humaines |
NZ593190A (en) | 2008-11-07 | 2013-01-25 | Baxter Int | Factor viii formulations |
WO2011095604A1 (fr) | 2010-02-04 | 2011-08-11 | Octapharma Biopharmaceuticals Gmbh | Prolongation de la demi-vie de protéines |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4657894A (en) * | 1983-03-31 | 1987-04-14 | Scripps Clinic & Research Foundation | New factor VIII coagulant polypeptides |
IE80858B1 (en) * | 1983-03-31 | 1999-04-21 | Scripps Research Inst | New factor viii coagulant polypeptides |
US4663280A (en) * | 1983-05-19 | 1987-05-05 | Public Health Research Institute Of The City Of New York | Expression and secretion vectors and method of constructing vectors |
JPH07106156B2 (ja) * | 1983-10-28 | 1995-11-15 | ジェネティックス、インスティチュ−ト | ファクタ−▲viii▼および関連生産物の製造 |
ZA852099B (en) * | 1984-03-26 | 1985-12-24 | Meloy Lab | Recombinant factor viii-c. |
FI86885C (fi) * | 1984-04-20 | 1992-10-26 | Genentech Inc | Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill |
JPH0634760A (ja) * | 1992-07-15 | 1994-02-10 | Hamamatsu Photonics Kk | 放射線計測装置及び核医学診断装置 |
-
1985
- 1985-01-11 DE DE3586402T patent/DE3586402T3/de not_active Expired - Lifetime
- 1985-01-11 DE DE2003199011 patent/DE10399011I1/de active Pending
- 1985-01-11 EP EP85100223A patent/EP0150735B2/fr not_active Expired - Lifetime
- 1985-01-11 DE DE2003199009 patent/DE10399009I1/de active Pending
- 1985-01-11 JP JP60002269A patent/JPH0826078B2/ja not_active Expired - Lifetime
- 1985-01-11 AT AT91113267T patent/ATE224445T1/de active
- 1985-01-11 DE DE2003199010 patent/DE10399010I1/de active Pending
- 1985-01-11 DE DE200412000028 patent/DE122004000028I1/de active Pending
- 1985-01-11 AT AT85100223T patent/ATE78871T1/de not_active IP Right Cessation
- 1985-01-11 DK DK013585A patent/DK165506C/da not_active IP Right Cessation
- 1985-01-11 DE DE3588242T patent/DE3588242T2/de not_active Expired - Lifetime
- 1985-01-11 EP EP91113267A patent/EP0466199B1/fr not_active Revoked
- 1985-01-11 EP EP00200860A patent/EP1006182A3/fr not_active Ceased
-
1991
- 1991-04-15 JP JP3082573A patent/JPH0634760B2/ja not_active Expired - Lifetime
-
1992
- 1992-03-25 DK DK038892A patent/DK169708B1/da not_active IP Right Cessation
- 1992-12-17 DK DK150992A patent/DK169724B1/da not_active IP Right Cessation
-
1993
- 1993-04-20 JP JP5092775A patent/JPH06105688A/ja active Pending
-
1999
- 1999-06-07 JP JP11160290A patent/JP2000023670A/ja active Pending
-
2001
- 2001-09-26 JP JP2001295193A patent/JP2002186487A/ja active Pending
-
2003
- 2003-03-18 LU LU91014C patent/LU91014I2/fr unknown
- 2003-03-18 LU LU91013C patent/LU91013I2/fr unknown
- 2003-03-18 LU LU91015C patent/LU91015I2/fr unknown
- 2003-03-18 NL NL300118C patent/NL300118I2/nl unknown
- 2003-03-18 NL NL300120C patent/NL300120I1/nl unknown
- 2003-03-18 NL NL300119C patent/NL300119I1/nl unknown
-
2004
- 2004-06-25 NL NL300153C patent/NL300153I1/nl unknown
- 2004-06-26 LU LU91087C patent/LU91087I2/fr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
LU91013I2 (fr) | ReFacto (Moroctocog alfa) dans toutes ses formes couvertes par le brevet de base | |
BR8606615A (pt) | Polipeptideos complementares a peptideos ou proteinas tendo uma sequencia de aminoacidos ou sequencia de codificacao de nucleotidios conhecida ao menos parcialmente e metodos de projeto dos mesmos | |
DK532284A (da) | Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser | |
ATE185350T1 (de) | Synthetische antigene zum nachweis von antikörpern gegen hepatitis c virus | |
ATE438657T1 (de) | Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung. | |
FR2660757B1 (fr) | Procede d'identification ou de dosage de proteines et applications. | |
ATE167301T1 (de) | Gruppe von getrennten peptiden | |
DE3881023D1 (de) | Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten. | |
DE69426209D1 (de) | Stannius- körperchen -protein, stanniocalcin | |
DE68925043D1 (de) | Synthetische Peptide und deren Mischungen für den Nachweis von HIV-Antikörpern | |
DK0418590T3 (da) | Antistoffer, fremstilling deraf og anvendelse deraf | |
KR950018049A (ko) | 사람 dna 토포이소머라제 제i형의 돌연변이체 단백질 | |
KR890009417A (ko) | 모노크로날 항체의 제조방법 및 그것의 이용방법 | |
GR1000377B (el) | Νεα πρωτεινη αναγνωρισεως της κυησεως σε θηλαστικα εφαρμογες στην προωρη ανιχνευση της κυησεως και μεθοδος παρασκευης της εν λογω πρωτεινης. |